Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics.
Saved in:
| Title: | Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics. |
|---|---|
| Authors: | Charrez B; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States., Charwat V; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States., Siemons BA; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States., Goswami I; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States., Sakolish C; Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States., Luo YS; Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States., Finsberg H; Simula Research Laboratory, Oslo, Norway., Edwards AG; Department of Pharmacology, School of Medicine, University of California at Davis, Davis, CA, United States., Miller EW; Department of Chemistry, University of California at Berkeley, Berkeley, CA, United States.; Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, United States.; Helen Wills Neuroscience Institute, University of California at Berkeley, Berkeley, CA, United States., Rusyn I; Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States., Healy KE; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States.; Department of Materials Science and Engineering, University of California at Berkeley, Berkeley, CA, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2021 Aug 04; Vol. 12, pp. 684252. Date of Electronic Publication: 2021 Aug 04 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2021.684252 |
